Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Pharmacy Practice: An Update on Cancer Chemoprevention
1
x
$
0.00
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
1
x
$
10.00
Strategies for Treatment-Resistant Depression
1
x
$
30.00
Indira Varia, MD: Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
1
x
$
30.00
Mechanism of Action of Antidepressants
1
x
$
30.00
Paroxetine Treatment of Generalized Anxiety Disorder
1
x
$
30.00
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
1
x
$
30.00
The Metabolism of Prostate Malignancy: Insight Into the Pathogenesis of Prostate Cancer and New Approaches for Its Diagnosis and Treatment
1
x
$
0.00
ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 3 - Full Issue Stacked PDF
1
x
$
60.00
Intravenous Lidocaine for the Management of Chronic Pain: A Narrative Review of Randomized Clinical Trials
1
x
$
30.00
Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
1
x
$
30.00
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
1
x
$
30.00
View Cart
Checkout
Home
Store
“The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
$
30.00
Add to cart
Details
The Effect of Food on the Absorption of Oral Ziprasidone
$
30.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Innovative Treatment Strategies With Anticonvulsants: A Focus on Bipolar Disorder
$
10.00
Add to cart
Details
Generalized Anxiety Disorder – A Doctor’s Guide
$
15.00
Add to cart
Details
Atypical Anti psychotic Drugs – A Doctor’s Guide
$
15.00
Add to cart
Details
Depression Rating Scales – A Doctor’s Guide
$
15.00
Add to cart
Details
Amisulpride for Clozapine Induced Sialorrhea
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Antipsychotic Treatment of Autistic Shutdowns—A Case Study
$
30.00
Add to cart
Details
Akinetic Mutism Following Bilateral Infarcts Associated with a Mitral Valve Papillary Fibroelastoma
$
30.00
Add to cart
Details
Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal
$
30.00
Add to cart
Details
Previous
1
…
23
24
25
…
44
Next
Page load link
Go to Top
